| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.3 | 0.07 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.28 | 0.09 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.21 | 0.09 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0009 |